Cutler Group LP Rapt Therapeutics, Inc. Call Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Jan 18, 2022	SELL	$29.5 - $39.5 $8,850 - $11,850	-300 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$29.86 - $39.47 $564,354 - $745,983	-18,900 Reduced 98.44%	300 $0
Q2 2021 Jul 19, 2021	BUY	$17.99 - $40.02 $302,232 - $672,336	16,800 Added 700.0%	19,200 $152,000
Q1 2021 Apr 26, 2021	BUY	$16.0 - $24.46 $12,800 - $19,568	800 Added 50.0%	2,400 $6,000
Q4 2020 Jan 21, 2021	BUY	$15.89 - $40.87 $25,424 - $65,391	1,600 New	1,600 $6,000

78.4M

213K

16.9K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $35.6M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.